中国医药导报
中国医药期刊欢迎您 今天是   2025年4月3日星期四
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  论著 本期目录 | 过刊浏览 | 高级检索 |
衰老相关分泌表型相关的lncRNAs模型预测肝细胞癌患者预后的构建和验证
周丁杰  戈伟  曹德东
武汉大学人民医院肿瘤中心,湖北武汉   430060
Construction and validation of a senescence-associated secretory phenotype associated lncRNAs model to predict prognosis in patients with hepatocellular carcinoma
ZHOU Dingjie   GE Wei   CAO Dedong
Oncology Center, Renmin Hospital of Wuhan University, Hubei Province, Wuhan   430060, China
全文: PDF (2546 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 构建衰老相关分泌表型(SASP)相关的可独立预测肝细胞癌(HCC)预后的风险模型,提高HCC的临床疗效。 方法 在癌症基因组学图谱(TCGA)数据库中获取HCC的测序数据及临床数据并分离出lncRNAs;在GeneCard网站中检索并筛选出相关系数>7的SASP相关基因,利用R语言“limma”包筛选出差异表达的SASP相关的基因及对应的lncRNAs。利用Cox回归分析和lasso构建SASP相关的lncRNAs预测模型,根据样本的风险评分中位值将HCC患者分为高风险组、低风险组,采用Kaplan-Meier曲线进行生存分析。利用单样本基因集富集分析(ssGSEA)来研究样本的风险评分和免疫状态之间的联系。 结果 从TCGA数据库中获取了374个肿瘤样本和50个正常组织样本,筛选出6个SASP相关的lncRNAs组成预后模型,计算出各样本的风险评分。生存分析显示,低风险组患者的预后优于高风险组患者的预后。风险模型1年生存受试者操作特征曲线的曲线下面积0.812。单因素和多因素回归分析显示,患者风险评分是HCC预后的独立危险因素(OR>1,P<0.05)。ssGSEA结果显示,高风险组免疫检查点特异性靶点和相关通路的表达水平更高。 结论 本研究成功构建SASP相关的lncRNAs风险模型,风险模型可独立预测HCC患者的预后情况。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
周丁杰  戈伟  曹德东
关键词 肝细胞癌衰老相关分泌表型LncRNA生物标志物诊断
    
Abstract:Objective To construct a senescence-associated secretory phenotype(SASP) related risk model that can independently predict the prognosis of hepatocellular carcinoma (HCC), and to improve the clinical efficacy of HCC. Methods Sequencing and clinical data of HCC were obtained from the cancer genome atlas(TCGA) database, and lncRNA were isolated. SASP related genes with correlation coefficient > seven were searched and screened from the GeneCard website, and genes related to differentially expressed SASP associated lncRNAs were screened using the R language “limma” package. Cox regression analysis and lasso were used to construct the lncRNAs prediction model related to SASP. HCC patients were divided into high-risk group and low-risk group according to the median risk score of the samples. Kaplan-Meier curve was used for survival analysis. Single sample gene set enrichment analysis (ssGSEA) was used to investigate the association between risk scores and immune status in samples. Results A total of 374 tumor samples and 50 normal tissue samples were obtained from the TCGA database. Six lncRNAs associated with SASP were selected form a prognostic model, and the risk scores of each sample were calculated. Survival analysis showed that the prognosis of patients in the low-risk group was better than that in the high-risk group. Area under one-year survival receiver operating characteristic curve of risk model was 0.812. Univariate and multivariate regression analysis showed that patient risk score was an independent risk factor for HCC prognosis (OR > 1, P < 0.05). ssGSEA results showed higher expression levels of immune checkpoint specific targets and associated pathways in the high-risk group. Conclusion In this study, the SASP-related lncRNAs risk model is successfully constructed, and the risk model can independently predict the prognosis of HCC patients.
Key wordsHepatocellular carcinoma    Senescence-associated secretory phenotype    LNcRNA    Biomarker    Diagnosis
    
基金资助:国家自然科学基金青年科学基金资助项目(81700208)。
通讯作者: 戈伟(1960.5-),男,博士,副主任医师;研究方向:肺癌、消化道肿瘤、淋巴瘤。   
作者简介: 周丁杰(1997.11-),男,武汉大学第一临床学院2020级肿瘤学专业在读硕士研究生;研究方向:肿瘤衰老与肿瘤代谢。
引用本文:   
周丁杰  戈伟  曹德东. 衰老相关分泌表型相关的lncRNAs模型预测肝细胞癌患者预后的构建和验证[J]. 中国医药导报, 2023, 20(25): 12-19.
ZHOU Dingjie GE Wei CAO Dedong. Construction and validation of a senescence-associated secretory phenotype associated lncRNAs model to predict prognosis in patients with hepatocellular carcinoma. 中国医药导报, 2023, 20(25): 12-19.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.25.02     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I25/12

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司